Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06583148

A Smoke-Free Home Intervention in Tribal Communities

Assessing the Effectiveness of a Smoke-Free Home Program in Tribal Communities

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
575 (estimated)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.

Detailed description

PRIMARY OBJECTIVE: I. To assess the effectiveness of a smoke-free homes intervention for tribal communities. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2. GROUP II: Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up. After completion of study intervention, participants are followed up at 3 and 6 months.

Conditions

Interventions

TypeNameDescription
OTHERBest PracticeReceive usual care
BEHAVIORALSmoking Cessation InterventionReceive the smoke-free home program
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2024-11-15
Primary completion
2028-01-31
Completion
2029-01-31
First posted
2024-09-03
Last updated
2025-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06583148. Inclusion in this directory is not an endorsement.